Can Hydroxyzine and Pristiq Be Given Together?
Yes, hydroxyzine can be given concurrently with Pristiq (desvenlafaxine), but this combination requires careful monitoring for QT prolongation and additive sedative effects.
Key Safety Considerations
QT Prolongation Risk
The primary concern with this combination is additive QT interval prolongation. Both medications are listed as QT-prolonging agents 1:
- Hydroxyzine appears on the list of QT-interval-prolonging antihistamines in pediatric guidelines 1
- Desvenlafaxine (Pristiq) is an SNRI that, like other serotonergic antidepressants, carries potential cardiac risks
When combining these medications:
- Obtain a baseline ECG, particularly in patients over 40 years or with cardiac risk factors 1
- Monitor for symptoms of cardiac arrhythmias (palpitations, syncope, dizziness)
- Avoid additional QT-prolonging medications when possible
- Use caution in patients with electrolyte abnormalities, especially hypokalemia
Serotonin Syndrome Risk
While hydroxyzine is not primarily serotonergic, the FDA label for Pristiq warns about serotonin syndrome when combining with other agents 2. However, hydroxyzine does not significantly contribute to serotonin syndrome risk and has actually been studied in combination with SSRIs without major serotonergic complications 3, 4.
Sedation and CNS Effects
Both medications can cause:
Counsel patients to:
- Avoid operating heavy machinery or driving until they know how the combination affects them
- Avoid alcohol, which potentiates CNS depression 2
- Be aware that sedation may be more pronounced initially
Clinical Context for Use
This combination may be appropriate when:
Treating comorbid anxiety and depression - Hydroxyzine provides rapid anxiolytic effects while Pristiq addresses underlying depression 6, 4
Managing initial SSRI/SNRI activation - Hydroxyzine can help with anxiety or agitation that sometimes occurs when starting antidepressants 4
Addressing insomnia - Hydroxyzine at bedtime may help with sleep disturbances common in depression 7
Practical Prescribing Approach
Start conservatively:
- Pristiq: 50 mg once daily (standard starting dose) 2
- Hydroxyzine: 10-25 mg at bedtime or 25-50 mg divided doses 8
Monitor closely:
- First 2-4 weeks: Assess for excessive sedation, dizziness, or cardiac symptoms
- Obtain ECG if patient has risk factors for QT prolongation
- Reassess need for hydroxyzine after 2-4 weeks, as it's typically used short-term
Important Caveats
Avoid or use extreme caution in:
- Patients with known QT prolongation or cardiac conduction abnormalities 1, 9
- Elderly patients (increased sensitivity to anticholinergic and sedative effects) 5, 10
- Patients on multiple CNS-active medications 10
- Severe hepatic impairment (hydroxyzine contraindicated) 8
- Severe renal impairment (adjust hydroxyzine dose) 8
Drug interaction note: Desvenlafaxine has minimal CYP450 interactions 11, so the combination is not problematic from a pharmacokinetic standpoint.
Bottom Line
This is a clinically reasonable combination when used judiciously for appropriate indications, with the main precaution being cardiac monitoring for QT prolongation in at-risk patients. The combination has been used in clinical practice 4 and hydroxyzine has been studied with other serotonergic antidepressants without prohibitive safety concerns 3. However, hydroxyzine should generally be used short-term (weeks, not months) given its sedating and anticholinergic properties 5, 7.